Buys
Open market- Shares
- +48,544
- Avg price
- $2.06
- Total value
- +$100,001
Lee T. Schalop - Director at Lantern Pharma Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- LTRN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Lee T. Schalop in Lantern Pharma Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +48,544
- Share %
- 100%
- Total value
- +$100,001
Reported holdings for Lee T. Schalop in Lantern Pharma Inc.
Form 4 holding
Director
Lantern Pharma Inc.
- Security class
- Common stock, $0.001 par value
- Shares / value
- 48,544
- Estimated value
- $100,000
- Report date
- 12 May 2026
- Price
- $2.06
- Ownership
- Direct
Form 4 holding
Director
Lantern Pharma Inc.
- Security class
- Common stock purchase warrant (Right to Buy)
- Shares / value
- 48,544
- Estimated value
- Report date
- 12 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Lantern Pharma Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 18,460
- Estimated value
- Report date
- 09 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Lee T. Schalop in Lantern Pharma Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.